Skip to main content
. 2023 Mar 16;128(10):1916–1921. doi: 10.1038/s41416-023-02214-0

Table 1.

Baseline clinical and genomic characteristics of advanced PDAC patients.

Variable All (N = 263)
Age, median (range) 64 (19–84)
Sex
  Male 157 (60%)
  Female 106 (40%)
ECOG
  0 98 (37%)
  ≥1 165 (63%)
Stage
  Locally advanced 37 (14%)
  Metastatic 226 (86%)
Chemotherapy
  FOLFIRINOX 143 (54%)
  Gemcitabine and nab-paclitaxel 98 (37%)
  Other 7 (3%)
  None 15 (6%)
Moffitt subtype
  Classical 198 (80%)
  Basal-like 49 (20%)
HRDetect
  >0.7 31 (13%)